Article Information
History
- October 1, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Elena Consolaro, MD1,
- Fredy Suter, MD2,
- Nadia Rubis, RES NURSE†,3,
- Stefania Pedroni, MD1,
- Chiara Moroni, MD1,
- Elena Pastò, MD1,
- Maria Vittoria Paganini, MD1,
- Grazia Pravettoni, MD4,
- Umberto Cantarelli, MD5,
- Norberto Perico, MD*,3,
- Annalisa Perna, MSC3,
- Tobia Peracchi, STATSCID3,
- Piero Ruggenenti, MD*,2,3 and
- Giuseppe Remuzzi, MD*,3
- 1ATS Insubria, Varese, Italy
- 2Azienda Socio-Sanitaria Territoriale (ASST) Papa Giovanni XXIII, Bergamo, Italy
- 3Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy
- 4Ospedale Circolo di Busto Arsizio, Varese, Italy
- 5ASL Teramo, Teramo, Italy
- ↵†Correspondence to: Nadia Rubis Res Nurse, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro di Ricerche Cliniche per Malattie Rare Aldo e Cele Daccò, Via GB Camozzi 3, 24020 Ranica, Bergamo, Italy. Email: nadia.rubis{at}marionegri.it
↵* These authors have contributed equally to this work
Posted October 01, 2021.
A HOME-TREATMENT ALGORITHM BASED ON ANTI-INFLAMMATORY DRUGS TO PREVENT HOSPITALIZATION OF PATIENTS WITH EARLY COVID-19: A MATCHED-COHORT STUDY (COVER 2)
